Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
10/21/2010 | US20100267006 Method for detection of cirulent strain of influenza type-a virus |
10/21/2010 | US20100266624 Hepatitis-c virus testing |
10/21/2010 | US20100266620 Immunoconjugates for treatment of infectious diseases |
10/21/2010 | US20100266619 Neutralizing Antibodies and Methods of Use Thereof |
10/21/2010 | US20100266618 Compositions and methods for augmenting activity of oncolytic viruses |
10/21/2010 | US20100266617 Antibodies to human programmed death receptor pd-1 |
10/21/2010 | US20100266616 Polypeptides, antibody variable domains and antagonists |
10/21/2010 | US20100266614 Ultra high affinity neutralizing antibodies |
10/21/2010 | US20100266613 Anti-tnf-alpha antibodies and their uses |
10/21/2010 | US20100266611 Enhancement of Immune Responses By 4-1BB-Binding Agents |
10/21/2010 | US20100266609 Antibody Molecules Which Bind IL-17A and IL-17F |
10/21/2010 | US20100266606 Antibody therapy for highly pathogenic avian influenza virus |
10/21/2010 | US20100266605 Use of a cd28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effect |
10/21/2010 | US20100266603 Monoclonal Antibody Specific to Ochratoxin A |
10/21/2010 | US20100266601 Antibodies that inhibit tslp activity |
10/21/2010 | US20100266599 Human receptor proteins; related reagents and methods |
10/21/2010 | US20100266598 Peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
10/21/2010 | US20100266597 Cytokine receptor zcytor17 multimers |
10/21/2010 | US20100266596 Therapeutic antibody purification method and method of use |
10/21/2010 | US20100266595 Treatment of insulin-resistant disorders |
10/21/2010 | US20100266593 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders |
10/21/2010 | US20100266592 Therapeutic antennapedia-antibody molecules and methods of use thereof |
10/21/2010 | US20100266586 Variable antibodies |
10/21/2010 | US20100266585 Monoclonal Antibodies Specific to Hemagglutinin and Neuraminidase from Influenza Virus H5-Subtype or N1-Subtype and Uses Thereof |
10/21/2010 | US20100266584 Antibodies against the ectodomain of erbb3 and uses thereof |
10/21/2010 | US20100266583 Inhibition of il-17 production |
10/21/2010 | US20100266582 Inhibition of il-17 production |
10/21/2010 | US20100266580 Translocation and mutant tnk1 kinase in human lymphoma |
10/21/2010 | US20100266579 Treatment of inflammatory diseases |
10/21/2010 | US20100266577 Method of Cancer Treatment with Antagonists of FAS Inhibitors |
10/21/2010 | US20100266576 Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applications |
10/21/2010 | US20100266575 SOLUBLE FMS-LIKE TYROSINE KINASE-1 (sFLT-1) ANTIBODY AND RELATED COMPOSITION, KIT, METHODS OF USING, AND MATERIALS AND METHOD FOR MAKING |
10/21/2010 | US20100266542 Receptor coupling agents and therapeutic uses thereof |
10/21/2010 | US20100266533 Death Domain Containing Receptors |
10/21/2010 | US20100266531 Il-17 binding proteins |
10/21/2010 | US20100266530 FcRN ANTIBODIES AND USES THEREOF |
10/21/2010 | US20100266503 Breast Cancer Methods, Medicaments and Agents |
10/21/2010 | US20100266502 Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient |
10/21/2010 | US20100266497 Internalizing Anti-CD74 Antibodies and Methods of Use |
10/21/2010 | US20100266494 Treatment of cancer with novel anti-il13 monoclonal antibodies |
10/21/2010 | US20100266493 Agonist antibodies against tshr |
10/21/2010 | US20100266490 Metalloproteinase Binding Proteins |
10/21/2010 | CA2758967A1 New methods of making an antibody and compositions thereof |
10/21/2010 | CA2758964A1 Anti-tnf-.alpha. antibodies and their uses |
10/21/2010 | CA2758751A1 Antibodies against prostate specific membrane antigen |
10/21/2010 | CA2758585A1 B-lymphocyte targeting agents for use in a method for the treatment of a disease |
10/21/2010 | CA2758449A1 Treatment of inflammatory diseases by inhibiting cold-inducible rna-binding protein (cirp) |
10/21/2010 | CA2758438A1 Affinity material |
10/21/2010 | CA2758378A1 Therapeutic antennapedia-antibody molecules and methods of use thereof |
10/21/2010 | CA2757382A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use |
10/21/2010 | CA2756973A1 Use of trifunctional bispecific antibodies for the treatment of tumors associated with cd133+/epcam+cancer stem cells |
10/21/2010 | CA2669470A1 Assay for detecting cathepsin k activity in bone, cartilage and/or soft tissue |
10/20/2010 | EP2241887A2 Diagnostics, drug screening and treatment for cancer |
10/20/2010 | EP2241885A1 Agent and method for diagnosis on the occurrence of alzheimer's disease or the tendency to develop alzheimer's disease |
10/20/2010 | EP2241625A1 Proteinase K resistant surface protein of neisseria meningitidis |
10/20/2010 | EP2241623A2 Monoclonal antibody against a human cytokine receptor |
10/20/2010 | EP2241622A2 Human trk receptors and their derivatives |
10/20/2010 | EP2241578A1 Anti-cldn6 antibody |
10/20/2010 | EP2241577A1 Anti-CD37 antibodies |
10/20/2010 | EP2241576A1 Use of trifunctional bispecific antibodies for the treatment of tumors associated with CD133+/EpCAM+ cancer stem cells |
10/20/2010 | EP2241332A1 Therapeutic agent for pruritus |
10/20/2010 | EP2241331A2 Novel anti-DC-SIGN antibodies |
10/20/2010 | EP2241330A1 Contraceptive methods and compositions related to proteasomal interference |
10/20/2010 | EP2241329A2 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness |
10/20/2010 | EP2241323A1 Tenascin-W and brain cancers |
10/20/2010 | EP2240517A1 Fdf03 antibodies and uses thereof |
10/20/2010 | EP2240516A1 Methods and agents for improving targeting of cd138 expressing tumor cells |
10/20/2010 | EP2240515A1 Antigen-binding polypeptides against cartilage degeneration |
10/20/2010 | EP2240203A1 Alpha 5 - beta 1 antibodies and their uses |
10/20/2010 | EP2240196A2 Clusterin derived peptide |
10/20/2010 | EP1687338B1 Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses thereof |
10/20/2010 | EP1407269B1 A method for diagnosing a person having multiple sclerosis |
10/20/2010 | EP1366366B1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers |
10/20/2010 | EP0710280B1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
10/20/2010 | CN101868478A Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof |
10/20/2010 | CN101868477A Novel rabbit antibody humanization methods and humanized rabbit antibodies |
10/20/2010 | CN101864447A Construction of prokaryotic expression vector of grass carp reovirus outer capsid protein and preparation method of polyclonal antibody |
10/20/2010 | CN101864398A Monoclonal antibody of anti-gonadotropin-releasing hormone receptor and application thereof |
10/20/2010 | CN101863981A Preparation method of anti-bisphenol A monoclonal antibody |
10/20/2010 | CN101863980A Whole human source anti-vascular endothelial cell growth factor receptor 2 single chain antibody |
10/20/2010 | CN101863979A Monoclonal antibody capable of resisting chlamys farrei particle blood corpuscle and preparation method thereof |
10/20/2010 | CN101863978A Human source anti-rabies virus Fab antibody, cross linking method thereof with nanometer particles and application thereof |
10/20/2010 | CN101863977A J substock lymphoid leuoosis-resistant polyclonal antibody and preparation method thereof |
10/20/2010 | CN101863976A Preparation method of EV71 virus antibody |
10/20/2010 | CN101863975A HBV (Hepatitis B Virus) preS1 B cell epitope peptide, hybridoma cell strain prepared by same and application |
10/20/2010 | CN101863970A Anti-Pf332-DBL region monoclonal antibody capable of restraining invasion of plasmodiumfalciparum |
10/19/2010 | US7816578 produces antibodies comprising two human immunoglobulin loci for use in the treatmnent of cardiovascular, infections, cancer and autoimmune disorders |
10/19/2010 | US7816500 Antibody SACK-1 that binds CD44 glycoforms |
10/19/2010 | US7816499 Antibody that binds histone deacetylase; transcription repressor activity and deacetylate cellular substrates; treatment of cell proliferation disease |
10/19/2010 | US7816498 has a titer in the range of mg/mL meeting requirements for permissible exposure limit (PEL) of toluene, exhibits no cross-reactivity with a carrier protein and exhibits higher competitive inhibition in response to an increasing concentration of hippuric acid; for diagnosing hallucinogenic substances |
10/19/2010 | US7816497 Compositions and methods for inhibiting drusen complement components C3a and C5a for the treatment of age-related macular degeneration |
10/19/2010 | US7816496 Carbonic anhydrase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
10/19/2010 | US7816493 Carbonic anhydrase for use diagnostic/prognostic tool in detectingf cell proliferative disorders of breast |
10/19/2010 | US7816334 Nucleic acid construct and nucleic acid expression vectors directing expression of a fusion protein consisting of a disease peptide antigen and a first domain of FrC of tetanus toxin; vaccines |
10/19/2010 | US7816319 Methods and products for manipulating uncoupling protein expression |
10/19/2010 | US7816108 producing ethanol by providing a polypeptide having alpha-amylase activity, contacting a starch-comprising composition with the polypeptide to produce a sugar, and fermenting the sugar to produce ethanol |
10/19/2010 | US7816097 Nucleic acid sequence coding Mammastatin; protein useful in diagnosis, therapy fo breast cancer ; antigrowth agents |
10/19/2010 | US7816089 Methods for diagnosing and treating pediatric neoplasms |
10/19/2010 | US7816075 treating a human afflicted with condition characterized by elevated serum triglyceride or very low density lipoprotein (VLDL), comprising the step of administering an inhibitor of human delta-9 stearoyl-CoA desaturase (SCD1) activity; coronary artery disease, Type II diabetes, obesity |
10/19/2010 | US7815916 Using human T cell leukemia virus type III (HTLV-III) RNA to diagnose, treat and prevent infection by human aquired immunodeficiency virus; viricides |